claim
Neuroimaging studies in psychedelic drug development can be adapted by using different PET ligands specific to the pharmacology of the compounds, utilizing other MRI modalities, or employing particular tasks and stimuli.
Authors
Sources
- Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com via serper
Referenced by nodes (3)
- PET concept
- neuroimaging concept
- Magnetic Resonance Imaging concept